Cancer

Immunovaccine Inc, Nova Scotia, Canada
Liposomes deliver an immune hit to cancer cells

Marcus Butler, Dana Farber Cancer Centre
Killer T Cells Trained for Long-lasting Anti-Cancer Effects

John Webb, British Columbia Cancer Agency
High-grade Ovarian Cancer: MHC Pentamers are Used to Investigate Immunotherapy Prospects

 

Ingerid Abrahamsen, Oslo University Hospital, Oslo Allogeneic T Cells May Be Targeted to B Cell LeukemiaErlend Stronen, Radiumhospitalet Oslo Pentamers Identify Allo-restricted T Cells in Study to Advance Research Into Cancer Immunotherapy

Richard Harrop, Oxford Biomedica
Novel Epitope Detection in Phase II Trial for Colorectal Cancer

Maxim Pavlenko, Karolinska University Hospital
Epitope Discovery in Prostate Cancer: Characterizing an Immunodominant CTL Epitope of PSA in Mice

Vincenzo Cerullo, University of Helsinki
First Ever Tumor-specific Response Observed for Human Patients in Oncolytic Adenovirus Cancer Gene Therapy Study

James Wells, King’s College London
New Adjuvant Drives Unprecedented Cytotoxic T Cell Response Providing a Potent Vaccine Development Platform

Hiro Yagi, Hamamatsu University School of Medicine
Pro5® Pentamers Integral in Successful Research Into Novel Immunization Strategy

Norman Woller, Edkulla Ramakrishna, Medizinische Hochschule Hannover
Using thinkpeptides to Improve Virotherapy Against Tumor Targets

More Cancer Publications Citing ProImmune